A defect in cortisol production in rheumatoid arthritis: Why are we still looking?

Rheumatology

Volumn 44, Issue 9, 2005, Pages 1097-1100

  Jessop, David S ^a   Harbuz, M S ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Adrenergic; Beta; Heart failure; Lymphocytes; Prognosis; Receptors; Signal transduction

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; CATECHOLAMINE; CORTICOSTERONE; CORTICOTROPIN; CORTISONE; GLUCOCORTICOID RECEPTOR; HYDROCORTISONE; INTERLEUKIN 1; INTERLEUKIN 6; NONSTEROID ANTIINFLAMMATORY AGENT; PRASTERONE SULFATE; PREDNISOLONE; TUMOR NECROSIS FACTOR ALPHA;

CATECHOLAMINE BLOOD LEVEL; CORTICOSTERONE BLOOD LEVEL; CORTICOTROPIN BLOOD LEVEL; CYTOKINE RELEASE; DRUG RESPONSE; GENETIC POLYMORPHISM; HELPER CELL; HORMONE METABOLISM; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYDROCORTISONE RELEASE; HYDROCORTISONE URINE LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MENTAL STRESS; PHYSICAL STRESS; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; REVIEW; RHEUMATOID ARTHRITIS; SALIVA LEVEL; STEROIDOGENESIS;

ARTHRITIS, RHEUMATOID; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; PITUITARY-ADRENAL SYSTEM;

EID: 24144463752     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/keh644     Document Type: Review

References (42)

1. Harbuz MS, Jessop DS. Is there a defect in cortisol production in rheumatoid arthritis? Rheumatology 1999;38:298-302.
2. Masi AT, Bijlsma JW, Chikanza IC, Pitzalis C, Cutolo M. Neuroendocrine, immunologic, and microvascular systems interactions in rheumatoid arthritis: Physiopathogenetic and therapeutic perspectives. Semin Arthritis Rheum 1999;29:65-81.
3. Cutolo M, Giusti M, Foppiani L et al. The hypothalamic-pituitary-adrenocortical and gonadal axis function in rheumatoid arthritis. Z Rheumatol 2000;59(Suppl. 2):II/65-9.
4. Zoli A, Lizzio MM, Ferlisi EM et al. ACTH, cortisol and prolactin in active rheumatoid arthritis. Clin Rheumatol 2002;21:289-93.
5. Kanik KS, Chrousos GP, Schumacher HR, Crane ML, Yarboro CH, Wilder RL. Adrenocorticotropin, glucocorticoid, and androgen secretion in patients with new onset synovitis/rheumatoid arthritis: Relations with indices of inflammation. J Clin Endocrinol Metab 2000;85:1461-6.
6. Straub RH, Paimela L, Peltomaa R, Scholmerich J, Leirisalo-Repo M. Inadequately low serum levels of steroid hormones in relation to interleukin-6 and tumor necrosis factor in untreated patients with early rheumatoid arthritis and reactive arthritis. Arthritis Rheum 2002;46:654-62.
7. Straub RH, Weidler C, Demmel B et al. Renal clearance and daily excretion of cortisol and adrenal androgens in patients with rheumatoid arthritis and systemic lupus erythematosus. Ann Rheum Dis 2004;63:961-8.
8. Rovensky J, Imrich R, Koska J et al. Cortisol elimination from plasma in premenopausal women with rheumatoid arthritis. Ann Rheum Dis 2003;62:674-6.
9. Vogl D, Falk W, Dorner M, Scholmerich J, Straub RH. Serum levels of pregnenolone and 17-hydroxypregnenolone in patients with rheumatoid arthritis and systemic lupus erythematosus: Relation to other adrenal hormones. J Rheumatol 2003;30:269-75.
10. Dekkers JC, Geenen R, Godaert GL, van Doornen LJ, Bijlsma JW. Diurnal rhythm of salivary cortisol levels in patients with recent-onset rheumatoid arthritis. Arthritis Rheum 2000;43:465-7.
11. Clow A, Thorn L, Evans P, Hucklebridge F. The awakening cortisol response: Methodological issues and significance. Stress 2004;7:29-37.
12. Catley D, Kaell AT, Kirschbaum C, Stone AA. A naturalistic evaluation of cortisol secretion in persons with fibromyalgia and rheumatoid arthritis. Arthritis Care Res 2000;13:51-61.
13. Cutolo M, Foppiani L, Prete C et al. Hypothalamic-pituitary-adrenocortical axis function in premenopausal women with rheumatoid arthritis not treated with glucocorticoids. J Rheumatol 1999;26:282-8.
14. Demir H, Kelestimur F, Tunc M, Kirnap M, Ozugul Y. Hypothalamo-pituitary-adrenal axis and growth hormone axis in patients with rheumatoid arthritis. Scand J Rheumatol 1999; 28:41-6.
15. Gutierrez MA, Garcia ME, Rodriguez JA, Mardonez G, Jacobelli S, Rivero S. Hypothalamic-pituitary-adrenal axis function in patients with active rheumatoid arthritis: A controlled study using insulin hypoglycemia stress test and prolactin stimulation. J Rheumatol 1999;26:277-81.
16. Rovensky J, Bakosova J, Koska J, Ksinantova L, Jezova D, Vigas M. Somatotropic, lactotropic and adrenocortical responses to insulin-induced hypoglycemia in patients with rheumatoid arthritis. Ann N Y Acad Sci 2002;966:263-70.
17. Imrich R, Rovensky J, Malis F et al. Low levels of dehydroepiandrosterone sulphate in plasma, and reduced sympathoadrenal response to hypoglycaemia in premenopausal women with rheumatoid arthritis. Ann Rheum Dis 2005;64:202-6.
18. Streeten HP, Phillips PE. Measurement of the HPA response to hypoglycaemic stress in human rheumatoid arthritis. Arthritis Rheum 1991;34(Suppl.):S156.
19. Harbuz MS, Korendowych E, Jessop DS, Crown AL, Lightman SL, Kirwan JR. Hypothalamo-pituitary-adrenal axis dysregulation in patients with rheumatoid arthritis after the dexamethasone/corticotrophin releasing factor test. J Endocrinol 2003;178:55-60.
20. van Everdingen AA, Huisman AM, Wenting MJ, van Reesema S, Jacobs JW, Bijlsma JW. Down regulation of glucocorticoid receptors in early-diagnosed rheumatoid arthritis. Clin Exp Rheumatol 2002; 20:463-8.
21. Huisman AM, Siewertsz van Everdingen AA, Wenting MJ et al. Glucocorticoid receptor up-regulation in early rheumatoid arthritis treated with low dose prednisone or placebo. Clin Exp Rheumatol 2003;21:217-20.
22. Ishizuka M, Hatori M, Suzuki T et al. Sex steroid receptors in rheumatoid arthritis. Clin Sci (Lond) 2004;106:293-300.
23. Straub RH, Dhabhar FS, Bijlsma JW, Cutolo M. How psychological stress via hormones and nerve fibers may exacerbate rheumatoid arthritis. Arthritis Rheum 2005;52:16-26.
24. Olsen N, Sokka T, Seehorn CL et al. A gene expression signature for recent onset rheumatoid arthritis in peripheral blood mononuclear cells. Ann Rheum Dis 2004;63:1387-92.
25. DeRijk RH, Schaaf MJ, Turner G et al. A human glucocorticoid receptor gene variant that increases the stability of the glucocorticoid receptor beta-isoform mRNA is associated with rheumatoid arthritis. J Rheumatol 2001;28:2383-8.
26. DeRijk RH, Schaaf M, de Kloet ER. Glucocorticoid receptor variants: clinical implications. J Steroid Biochem Mol Biol 2002; 81:103-22.
27. Wust S, Van Rossum EF, Federenko IS, Koper JW, Kumsta R, Hellhammer DH. Common polymorphisms in the glucocorticoid receptor gene are associated with adrenocortical responses to psychosocial stress. J Clin Endocrinol Metab 2004;89:565-73.
28. Masi AT, Aldag JC, Chatterton RT, Adams RF, Kitabchi AE. Adrenal androgen and glucocorticoid dissociation in premenopausal rheumatoid arthritis: A significant correlate or precursor to onset? Z Rheumatol 2000;59:54-61.
29. Masi AT. Hormonal and immunologic risk factors for the development of rheumatoid arthritis: An integrative physiopathogenetic perspective. Rheum Dis Clin North Am 2000;26:775-803.
30. Tengstrand B, Carlstrom K, Fellander-Tsai L, Hafstrom I. Abnormal levels of serum dehydroepiandrosterone, estrone, and estradiol in men with rheumatoid arthritis: High correlation between serum estradiol and current degree of inflammation. J Rheumatol 2003;30:2338-43.
31. Nell VP, Machold KP, Eberl G, Stamm TA, Uffmann M, Smolen JS. Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritis. Rheumatology 2004;43:906-14.
32. Dekkers JC, Geenen R, Godaert GL et al. Experimentally challenged reactivity of the hypothalamic pituitary adrenal axis in patients with recently diagnosed rheumatoid arthritis. J Rheumatol 2001;28:1496-504.
33. Pool AJ, Whipp BJ, Skasick AJ, Alavi A, Bland JM, Axford JS. Serum cortisol reduction and abnormal prolactin and CD4+/CD8+ T-cell response as a result of controlled exercise in patients with rheumatoid arthritis and systemic lupus erythematosus despite unaltered muscle energetics. Rheumatology 2004;43:43-8.
34. Jessop DS, Richards LJ, Harbuz MS. Effects of stress on inflammatory autoimmune disease: Destructive or protective? Stress 2005, in press.
35. Jessop DS. Central non-glucocorticoid inhibitors of the hypothalamo-pituitary-adrenal axis. J Endocrinol 1999;160:169-80.
36. Elenkov IJ. Systemic stress-induced Th2 shift and its clinical implications. Int Rev Neurobiol 2002;52:163-86.
37. Schmidt M, Weidler C, Naumann H, Grifka J, Scholmerich J, Straub RH. Arthritis Rheum 2004;50(Suppl.):S155.
38. Harbuz M. Neuroendocrinology of autoimmunity. Int Rev Neurobiol 2002;52:133-61.
39. Harkness JA, Richter MB, Panayi GS et al. Circadian variation in disease activity in rheumatoid arthritis. Br Med J 1982;284:551-4.
40. Cutolo M, Seriolo B, Craviotto C, Pizzorni C, Sulli A. Circadian rhythms in RA. Ann Rheum Dis 2003;62:593-6.
41. Cutolo M, Masi AT. Circadian rhythms and arthritis. Rheum Dis Clin North Am 2005;31:115-29.
42. Arvidson NG, Gudbjornsson B, Larsson A, Hallgren R. The timing of glucocorticoid administration in rheumatoid arthritis. Ann Rheum Dis 1997;56:27-31.